Ticker Scorecard - VYNE Basics Company: VYNE Therapeutics Inc. IPO Date: January 22, 2018 Sector: Healthcare Market Cap: $40.42M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 4.07% Avg Daily Range (30 D): $0.12 | 3.96% Avg Daily Range (90 D): $0.12 | 4.15% Institutional Daily Volume Avg Daily Volume: .1M Avg Daily Volume (30 D): .08M Avg Daily Volume (90 D): .09M Trade Size Avg Trade Size (Sh.): 33 Avg Trade Size (Sh.) (30 D): 197 Avg Trade Size (Sh.) (90 D): 213 Institutional Trades Total Inst.Trades: 33 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $.59M Avg Inst. Trade (90 D): $.59M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.91M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 31.93K     News Jun 26, 2024 @ 12:00 PM VYNE Therapeutics to Participate in Leerink Partne... Source: VYNE Therapeutics Inc. Jun 14, 2024 @ 1:01 PM Analyst Scoreboard: 4 Ratings For VYNE Therapeutic... Source: Benzinga Insights Jun 13, 2024 @ 1:02 PM VYNE Therapeutics Announces Dosing of First Partic... Source: VYNE Therapeutics Inc. May 9, 2024 @ 1:15 PM VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Mis... Source: Zacks Equity Research May 8, 2024 @ 12:10 PM Verve Therapeutics (VERV) Reports Q1 Loss, Tops Re... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $3.38 $-.29 $-.22 Diluted EPS $3.38 $-.29 $-.22 Revenue $ .49M $ .12M $ .2M Gross Profit $ $ $ Net Income / Loss $ -34M $ -12.16M $ -9.41M Operating Income / Loss $ -37.7M $ -13.09M $ -10.4M Cost of Revenue $ $ $ Net Cash Flow $ .82M $ -13.34M $ 10.54M PE Ratio 0.81     Splits Feb 13, 2023:   18:1 Feb 16, 2021:   4:1